Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1989-8-11
pubmed:abstractText
Guanine nucleotides were shown to alter N-methyl-d-aspartate (NMDA) receptor-effector coupling by competitive antagonism at the glutamate binding site, rather than via interaction with an intracellularly located GTP-binding protein. Thus, in contrast to known G-protein linked receptors, micromolar concentrations of guanine nucleotides and their analogs decreased both agonist [( 3H]glutamate) and antagonist [( 3H]-3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid binding to the NMDA receptor complex. The most potent compound, the GDP analog guanosine-5'-O-(2-thiodiphosphate) (GDP beta S), was studied in detail. GDP beta S exhibited almost 200-fold selectivity for the glutamate recognition site vs. the strychnine-insensitive glycine binding site. IC50 values were 2.7 +/- 1.4 and 484 +/- 97 microM, respectively. GDP beta S also inhibited N-[1-(2-thienyl)cyclohexyl-3H]piperidine binding (IC50 was 28.0 +/- 3.7 microM) in an NMDA-reversible fashion. [3H]-3-(2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid saturation binding studies revealed an increase in Kd from 263 +/- 49 (control) to 552 +/- 134 nM (8 microM GDP beta S) without any change in maximum binding (4.94 +/- 0.34 and 5.19 +/- 0.58 pmol/mg of protein, respectively). GDP beta S was also a competitive inhibitor of the following NMDA-stimulated responses: elevation of cyclic GMP in neonatal rat cerebellar slices, release of preloaded [3H]norepinephrine from superfused rat hippocampal slices and elevation of cytosolic calcium concentration in fura-2-loaded cultured rat forebrain neurons. IC50 values were 78.4, 53.4 and 1.6 microM, respectively. Finally, GDP beta S resembled known NMDA receptor antagonists in its ability to block NMDA receptor-induced seizures after i.c.v. administration.(ABSTRACT TRUNCATED AT 250 WORDS)
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0022-3565
pubmed:author
pubmed:issnType
Print
pubmed:volume
250
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
162-9
pubmed:dateRevised
2003-11-14
pubmed:meshHeading
pubmed-meshheading:2545857-Animals, pubmed-meshheading:2545857-Aspartic Acid, pubmed-meshheading:2545857-Binding, Competitive, pubmed-meshheading:2545857-Brain, pubmed-meshheading:2545857-Calcium, pubmed-meshheading:2545857-Cerebellum, pubmed-meshheading:2545857-Cerebral Cortex, pubmed-meshheading:2545857-Cyclic GMP, pubmed-meshheading:2545857-Cytosol, pubmed-meshheading:2545857-Guanine Nucleotides, pubmed-meshheading:2545857-Hippocampus, pubmed-meshheading:2545857-Intracellular Membranes, pubmed-meshheading:2545857-Kinetics, pubmed-meshheading:2545857-Male, pubmed-meshheading:2545857-N-Methylaspartate, pubmed-meshheading:2545857-Neurons, pubmed-meshheading:2545857-Norepinephrine, pubmed-meshheading:2545857-Rats, pubmed-meshheading:2545857-Rats, Inbred Strains, pubmed-meshheading:2545857-Receptors, N-Methyl-D-Aspartate, pubmed-meshheading:2545857-Receptors, Neurotransmitter, pubmed-meshheading:2545857-Synaptosomes
pubmed:year
1989
pubmed:articleTitle
Guanine nucleotides are competitive inhibitors of N-methyl-D-aspartate at its receptor site both in vitro and in vivo.
pubmed:affiliation
Merrell Dow Research Institute, Cincinnati, Ohio.
pubmed:publicationType
Journal Article